Evidence map›Paper›PMID 24091475›Full record

ArticleOncotarget2013

Small-Molecule targeting of translation initiation for cancer therapy.

Bertal H Aktas, Yuan Qiao, Esra Ozdelen, Roland Schubert, Sema Sevinc, Fred Harbinski, Luciano Grubissich, Samuel Singer, Jose A Halperin

Open access · hybridAbstract read
In one paragraph

Article in Oncotarget, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Gastric cardia adenocarcinoma microRNA profiling in Chinese patients.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  11. Article
  12. An inhibitor of HIV-1 protease modulates constitutive eIF2α dephosphorylation to trigger a specific integrated stress response.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Post-transcriptional regulation of long noncoding RNAs in cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Review
  18. Translational regulator eIF2α in tumor.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Bertal H AktasDepartment of Medicine, Brigham and Women's Hospital, Boston.
Yuan Qiao
Esra Ozdelen
Roland Schubert
Sema Sevinc
Fred Harbinski
Luciano Grubissich
Samuel Singer
Jose A Halperin
Harvard University · USBrigham and Women's Hospital · US

Funding

NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPYU19CA087427 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI HALPERIN, JOSE A · 2000 to 2004
$5.1M
Prostate Cancer Prevention by n-3 Unsaturated Fatty AcidsR01CA101034 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI HALPERIN, JOSE A · 2005 to 2008
$2.1M
INHIBITION OF TRANSLATION INITIATION IN CANCER THERAPYR01CA078411 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI HALPERIN, JOSE A · 1998 to 2005
$1.5M
NCI NIH HHS CA101034NCI NIH HHS CA78411NCI NIH HHS R01 CA078411NCI NIH HHS R01 CA101034NCI NIH HHS U19 CA087427NCI NIH HHS U19 CA87427
6 · The paper itself

Abstract

Translation initiation plays a critical role in the regulation of cell growth and tumorigenesis. We report here that inhibiting translation initiation through induction of eIF2α phosphorylation by small-molecular-weight compounds restricts the availability of the eIF2.GTP.Met-tRNAi ternary complex and abrogates the proliferation of cancer cells in vitro and tumor growth in vivo. Restricting the availability of the ternary complex preferentially down-regulates the expression of growth-promoting proteins and up-regulates the expression of ER stress response genes in cancer cells as well as in tumors excised from either animal models of human cancer or cancer patients. These findings provide the first direct evidence for translational control of gene-specific expression by small molecules in vivo and indicate that translation initiation factors are bona fide targets for development of mechanism-specific anti-cancer agents.

Indexed as

AnimalsAntineoplastic AgentsCell Cycle CheckpointsCell Line, TumorCell ProliferationChromansClotrimazoleCyclin D1Disease Models, AnimalEicosapentaenoic AcidEukaryotic Initiation Factor-2FemaleHumansMiceMice, Inbred DBAPeptide Chain Initiation, TranslationalAntineoplastic AgentsChromansClotrimazoleCyclin D1Eicosapentaenoic AcidEukaryotic Initiation Factor-2ThiazolidinedionesTroglitazone

Identifiers

PMID24091475
PMCPMC3858549
OpenAlexW2127571330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.